Biomarkers of neoadjuvant immunotherapy for locally advanced head and neck cancer: A systematic review and meta-analysis
This meta-analysis was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
This meta-analysis was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
What the study was
- Study design
- Meta-analysis
- Sample size
- 980
- Maturity
- Validated
- Journal
- Medicine
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.